ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Mechanical Heat Recovery Ventilation on House Dust Mite Sensitive Asthma

This study has been completed.

Sponsors and Collaborators: University of Glasgow
Chief Scientist's Office of the Scottish Executive
North Lanarkshire Council
South Lanarkshire Council
North Glasgow Primary Care Trust
Vent-axia Ltd
Scottish Power
Energy Action Scotland
Communities Scotland
Information provided by: University of Glasgow
ClinicalTrials.gov Identifier: NCT00148096
  Purpose

Asthma has become increasingly common in the UK, demanding our consideration of the cause. Many patients with asthma are allergic to house dust mites, which thrive in modern housing. Improving ventilation in the home has been shown to reduce dust mite levels, by reducing humidity levels. It is hoped that, by removing the dust mites from homes, asthma may improve. In this study, 140 volunteers will have their carpets steam-cleaned and new allergy bedding provided, before a team of architects installs a ventilation system in the loft. Half of the units will be switched on at the beginning of the study. The other half will be switched on in 12 months time, but only the architects know which units are active. The medical team will compare the asthma, and measures of inflammation in the airways, over that year.

It is due for completion in April 2007.


Condition Intervention Phase
Asthma
Device: Mechanical Heat Recovery Ventilation
Phase II

MedlinePlus related topics:   Allergy    Asthma   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
Official Title:   Randomised Controlled Trial of Mechanical Heat Recovery Ventilation on Asthma Control of Patients Allergic to the House Dust Mite

Further study details as provided by University of Glasgow:

Primary Outcome Measures:
  • morning Peak Flow [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • symptom scores [ Time Frame: 1 year ]
  • exacerbation rates [ Time Frame: 1 year ]
  • quality of life [ Time Frame: 1 year ]
  • spirometry [ Time Frame: 1 year ]

Enrollment:   119
Study Start Date:   February 2003
Study Completion Date:   April 2007

Arms Assigned Interventions
1: Placebo Comparator
Mechanical heat recovery ventilation units installed but not fully functional
Device: Mechanical Heat Recovery Ventilation
De-humidification without loss of heat
2: Active Comparator
Mechanical heat recovery ventilation unit installed and active
Device: Mechanical Heat Recovery Ventilation
De-humidification without loss of heat

Detailed Description:

The prevalence of asthma is rising sharply in the UK. The house dust mite is the most common trigger associated with asthma, thriving in the humid microclimate favoured by modern housing. Could this be redressed by investment in improved ventilation in local housing? In a pilot study in North Lanarkshire Council housing stock, we demonstrated that dust mite avoidance, in combination with installation of domestic mechanical heat recovery ventilation (MHRV), could inhibit the re-colonisation of house dust mites by reduction of indoor air humidity. In this second phase, a double blind randomized placebo- controlled trial will test the resultant effect on asthma. It will be complete in November 2006. 140 patients with asthma and house dust mite allergy are being recruited and all will have new bedding, mattress covers and carpets cleaned. All will have MHRV units installed in their home, but only half will be activated, before 12 months of environmental and clinical monitoring. The primary endpoint is morning peak flow rate. Secondary endpoints include symptom scores, spirometry, rates of exacerbations, quality-of-life, and economic evaluations. Demonstration that well ventilated, energy efficient dwellings improve the respiratory health of patients with allergic asthma could be of considerable importance in helping the NHS cope with the commonest chronic disease in Scotland.

  Eligibility
Ages Eligible for Study:   16 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • House dust mite sensitive
  • FEV1 greater than 50%
  • Symptomatic asthma or 12% reversibility on spirometry or 15%PEFR lability

Exclusion Criteria:

  • Multi-storey flat
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00148096

Locations
United Kingdom
Monklands General Hospital    
      North Lanarkshire, United Kingdom

Sponsors and Collaborators
University of Glasgow
Chief Scientist's Office of the Scottish Executive
North Lanarkshire Council
South Lanarkshire Council
North Glasgow Primary Care Trust
Vent-axia Ltd
Scottish Power
Energy Action Scotland
Communities Scotland

Investigators
Principal Investigator:     Prof Neil C Thomson, MD FRCP     The University of Glasgow    
  More Information


Asthma Research Unit website  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   CZB/4/47, CSO CZB/4/47 and BO/01/69
First Received:   September 2, 2005
Last Updated:   March 19, 2008
ClinicalTrials.gov Identifier:   NCT00148096
Health Authority:   United Kingdom: Research Ethics Committee

Keywords provided by University of Glasgow:
asthma  
house dust mite  
allergy  
housing
avoidance
humidity

Study placed in the following topic categories:
Lung Diseases, Obstructive
Hypersensitivity
Respiratory Tract Diseases
Lung Diseases
Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:
Immune System Diseases
Bronchial Diseases

ClinicalTrials.gov processed this record on October 14, 2008




Links to all studies - primarily for crawlers